Human mesenchymal stem cells isolated from olfactory biopsies but not bone enhance CNS myelination in vitro

GLIA

Volumn 61, Issue 3, 2013, Pages 368-382

  Lindsay, Susan L ^a   Johnstone, Steven A ^a   Mountford, Joanne C ^b   Sheikh, Saghir ^c   Allan, David B ^d   Clark, Louise ^c   Barnett, Susan C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^d QUEEN ELIZABETH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

CNS myelination; Glia; Human mesenchymal stem cells; Olfactory system

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA 3 TUBULIN; BETA TUBULIN; BIOLOGICAL MARKER; CYTOKERATIN 5; CYTOKERATIN 6; ENDOGLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NESTIN; NEUROTROPHIN RECEPTOR P75; PROTEOCHONDROITIN SULFATE; PROTEOCHONDROITIN SULFATE 4; SMOOTH MUSCLE ACTIN; STROMAL CELL DERIVED FACTOR 1; THY 1 ANTIGEN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL REGENERATION; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; CONDITIONED MEDIUM; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLOGY; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LAMINA PROPRIA; MESENCHYMAL STEM CELL; MYELINATION; NONHUMAN; OLFACTORY ENSHEATHING CELL; OLFACTORY SYSTEM; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ADOLESCENT; ADULT; AGED; ANIMALS; BONE AND BONES; BONE TRANSPLANTATION; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MYELIN SHEATH; NEUROGLIA; OLFACTORY MUCOSA; RATS; SPINAL CORD INJURIES; WOUND HEALING;

EID: 84872611610     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22440     Document Type: Article

References (82)

1. Alexander CL, Fitzgerald UF, Barnett SC. 2002. Identification of growth factors that promote long-term proliferation of olfactory ensheathing cells and modulate their antigenic phenotype. Glia 37: 349-364.
2. Amemori T, Jendelová P, Růzicková K, Arboleda D, Syková E. 2010. Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat. Cytotherapy 12: 212-225.
3. Arriola A, Kiel ME, Shi Y, McKinnon RD. 2010. Adjunctive MSCs enhance myelin formation by xenogenic oligodendrocyte precursors transplanted in the retina. Cell Res 20: 728-731.
4. Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH. 2009. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57: 1192-1203.
5. Bai L, Lennon DP, Caplan AI, Dechant A, Hecker J, Kranso J, Zaremba A, Miller RH. 2012. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15: 862-870.
6. Barnett SC, Chang L. 2004. Olfactory ensheathing cells and CNS repair: going solo or in need of a friend? Trends Neurosci 27: 54-60.
7. Barnett SC, Riddell JS. 2007. Olfactory ensheathing cell transplantation as a strategy for spinal cord repair--What can it achieve? Nat Clin Pract Neurol 3: 152-161.
8. Barnett SC, Alexander CL, Iwashita Y, Gilson JM, Crowther J, Clark L, Dunn LT, Papanastassiou V, Kennedy PG, Franklin RJ. 2000. Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 123: 1581-1588.
9. Bianco JI, Perry C, Harkin DG, Mackay-Sim A, Féron F. 2004. Neurotrophin 3 promotes purification and proliferation of olfactory ensheathing cells from human nose. Glia 45: 111-123.
10. Boomkamp SD, Riehle MO, Wood J, Olson MF, Barnett SC. 2012. The development of a rat in vitro model of spinal cord injury demonstrating the additive effects of Rho and ROCK inhibitors on neurite outgrowth and myelination. Glia 60: 441-456.
11. Bottenstein JE, Sato GH. 1979. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76: 514-517.
12. Boyd JG, Skihar V, Kawaja M, Doucette R. 2003. Olfactory ensheathing cells: Historical perspective and therapeutic potential. Anat Rec B New Anat 271: 49-60.
13. Bunge RP, Puckett WR, Hiester ED. 1997. Observations on the pathology of several types of human spinal cord injury with emphasis on the astrocyte response to penetrating injuries. Adv Neurol 72: 5-315.
14. Caddick J, Kingham PJ, Gardiner NJ, Wiberg M, Terenghi G. 2006. Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage Glia 54: 840-849.
15. Chan JR, Cosgaya JM, Wu YJ, Shooter EM. 2001. Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc Natl Acad Sci USA 98: 14661-14668.
16. Chen L, Tredget EE, Wu PY, Wu Y. 2008. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3: e1886.
17. Chernykh ER, Shevela EY, Leplina OY, Tikhonova MA, Ostanin AA, Kulagin AD, Pronkina NV, Muradov ZHM, Stupak VV, Kozlov VA. 2006. Characteristics of bone marrow cells under conditions of impaired innervation in patients with spinal trauma. Bull Exp Biol Med 141: 117-120.
18. Cho SR, Kim YR, Kang HS, Yim SH, Park CI, Min YH, Lee BH, Shin JC, Lim JB. 2009. Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone marrow in a rat model of spinal cord injury. Cell Transplant 18:12: 1359-1368.
19. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. 2008. Human mesenchymal stem cells stimulated by TNF-α LPS or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 294: C675-C682.
20. Croitoru-Lamoury J, Lamoury FM, Zaunders JJ, Veas LA, Brew BJ. 2007. Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFNbeta and Copaxone. J Interferon Cytokine Res 27: 53-64.
21. Delorme B, Nivet E, Gaillard J, Häupl T, Ringe J, Devèze A, Magnan J, Sohier J, Khrestchatisky M, Roman FS, Charbord P, Sensebé L, Layrolle P, Féron F. 2010. The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties. Stem Cells Dev 19: 853-866.
22. Deng YB, Liu Y, Zhu WB, Bi XB, Wang YZ, Ye MH, Zhou GQ. 2008. The co-transplantation of human bone marrow stromal cells and embryo olfactory ensheathing cells as a new approach to treat spinal cord injury in a rat model. Cytotherapy 10: 551-564.
23. Dobkin BH, Curt A, Guest J. 2006. Cellular transplants in China: Observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repai 20: 5-13.
24. Doucette R. 1990. Glial influences on axonal growth in the primary olfactory system. Glia 3: 433-449.
25. Farbman AI. 1990. Olfactory neurogenesis: Genetic or environmental controls? Trends Neurosci 13: 362-365.
26. Fawcett JW, Asher RA. 1999. The glial scar and central nervous system repair. Brain Res Bull 49: 377-391.
27. Féron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, Geraghty T, Mackay-Sim A. 2005. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 128: 2951-2960.
28. Féron F, Perry C, McGrath JJ, Mackay-Sim A. 1998. New techniques for biopsy and culture of human olfactory epithelial neurons. Arch Otolaryngol Head Neck 124: 861-866.
29. Franceschini IA, Barnett SC. 1996. Low-affinity NGF-receptor and E-N-CAM expression define two types of olfactory nerve ensheathing cells that share a common lineage. Dev Biol 173: 327-343.
30. Franklin RJ, Barnett SC. 2000. Olfactory ensheathing cells and CNS regeneration: The sweet smell of success? Neuron 28: 15-18.
31. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, Mantegazza R, Frassoni F, Mancardi G, Pedotti R, Uccelli A. 2007. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 61: 219-227.
32. Gorrie CA, Hayward I, Cameron N, Kailainathan G, Nandapalan N, Sutharsan R, Wang J, Mackay-Sim A, Waite PM. 2010. Effects of human OEC-derived cell transplants in rodent spinal cord contusion injury. Brain Res 1337: 8-20.
33. Graziadei PP, Graziadei GA. 1979. Neurogenesis and neuron regeneration in the olfactory systems of mammals. I. Morphological aspects of differentiation and structural organisation of the olfactory sensory neurons. J Neurocytol 8: 1-18.
34. Guest J, Herrera LP, Qian T. 2006. Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb-derived cells. Spinal Cord 44: 135-142.
35. Higginson JR, Barnett SC. 2011. The culture of olfactory ensheathing cells OECs--A distinct glial cell type. Exp Neurol 229: 2-9.
36. Huang H, Chen L, Xi H, Wang Q, Zhang J, Liu Y, Zhang F. 2008. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clin Transplant 22: 710-718.
37. Huang GT, Gronthos S, Shi S. 2009. Mesenchymal stem cells derived from dental tissues vs. those from other sources: Their biology and role in regenerative medicine. J Dent Res 88: 792-806.
38. Huard JM, Youngentob SL, Goldstein BJ, Luskin MB, Schwob JE. 1998. Adult olfactory epithelium contains multipotent progenitors that give rise to neurons and non-neural cells. J Comp Neurol 400: 469-486.
39. Ibrahim A, Li Y, Li D, Raisman G, El Masry WS. 2006. Olfactory ensheathing cells: Ripples of an incoming tide? Lancet Neurol 5: 453-457.
40. Ishibashi T, Lee PR, Baba H, Fields RD. 2009. Leukemia inhibitory factor regulates the timing of oligodendrocyte development and myelination in the postnatal optic nerve J Neurosci Res 87: 3343-3355.
41. Jiao J, Milwid JM, Yarmush ML, Parekkadan B. 2011. A mesenchymal stem cell potency assay. Methods Mol Biol 677: 221-231.
42. Kadoya K, Tsukada S, Lu P, Coppola G, Geschwind D, Filbin MT, Blesch A, Tuszynski MH. 2009. Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury. Neuron 64: 165-172.
43. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Schut D, Fehlings MG. 2010. Synergistic effects of transplanted adult neural stem/progenitor cells chondroitinase and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 30: 1657-1676.
44. Katsha AM, Ohkouchi S, Xin H, Kanehira M, Sun R, Nukiwa T, Saijo Y. 2011. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 19: 196-203.
45. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. 2006. Comparative analysis of mesenchymal stem cells from bone marrow umbilical cord blood or adipose tissue. Stem Cells 24: 1294-1301.
46. Kolf CM, Cho E, Tuan RS. 2007. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche self-renewal and differentiation. Arthritis Res Ther 9: 204.
47. Kuhn NZ, Tuan RS. 2010. Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis. J Cell Physiol 222: 268-277.
48. Leung CT, Coulombe PA, Reed RR. 2007. Contribution of olfactory neural stem cells to tissue maintenance and regeneration. Nat Neurosci 10: 720-726.
49. Li Y, Decherchi P, Raisman G. 2003. A promising therapeutic approach to spinal cord repair. J Neurosc 1:23: 727-731.
50. Li Y, Field PM, Raisman G. 2005. Olfactory ensheathing cells and olfactory nerve fibroblasts maintain continuous open channels for regrowth of olfactory nerve fibres. Glia 52: 245-251.
51. Lima C, Escada P, Pratas-Vital J, Branco C, Arcangeli CA, Lazzeri G, Maia CA, Capucho C, Hasse-Ferreira A, Peduzzi JD. 2010. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair 24: 10-22.
52. Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. 2006. Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J Spinal Cord Med 29: 191-203.
53. Lindsay SL, Riddell JS, Barnett SC. 2010. Olfactory mucosa for transplant-mediated repair: A complex tissue for a complex injury? Glia 58: 125-134.
54. Lu P, Yang H, Jones LL, Filbin MT, Tuszynski MH. 2004. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci 24: 6402-6409.
55. Mackay-Sim A, Féron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W, Fronek P, Gray C, Kerr G, Licina P, Nowitzke A, Perry C, Silburn PA, Urquhart S, Geraghty T. 2008. Autologous olfactory ensheathing cell transplantation in human paraplegia: A 3-year clinical trial. Brain 131: 2376-2386.
56. Miller RH, Bai L. 2007. Cellular approaches for stimulating CNS remyelination. Regen Med 2: 817-829.
57. Muñoz-Quiles C, Santos-Benito FF, Llamusí MB, Ramón-Cueto A. 2009. Chronic spinal injury repair by olfactory bulb ensheathing glia and feasibility for autologous therapy. J Neuropathol Exp Neurol 68: 1294-1308.
58. Murrell W, Féron F, Wetzig A, Cameron N, Splatt K, Bellette B, Bianco J, Perry C, Lee G, Mackay-Sim A. 2005. Multipotent stem cells from adult olfactory mucosa. Dev Dyn 233: 496-515.
59. Nakano N, Nakai Y, Seo T.B, Yamada Y, Ohno T, Yamanaka A, Nagai Y, Fukushima M, Suzuki Y, Nakatani T, Ide C. 2010. Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci Lett 8; 483: 57-61.
60. Nash B, Thomson CE, Linington C, Arthur AT, McClure JD, McBride MW, Barnett SC. 2011. Functional duality of astrocytes in myelination. J Neurosci 14; 31: 13028-13038.
61. Neuhuber B, Timothy Himes B, Shumsky JS, Gallo G, Fischer I. 2005. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 1035: 73-85.
62. Navarro X, Valero A, Gudiño G, Forés J, Rodríguez FJ, Verdú E, Pascual R, Cuadras J, Nieto-Sampedro M. 1999. Ensheathing glia transplants promote dorsal root regeneration and spinal reflex restitution after multiple lumbar rhizotomy. Ann Neurol 45: 207-215.
63. Plant GW, Christensen CL, Oudega M, Bunge MB. 2003. Delayed transplantation of olfactory ensheathing glia promotes sparing/regeneration of supraspinal axons in the contused adult rat spinal cord. JNeurotrauma 20: 1-16.
64. Raisman G. 2001. Olfactory ensheathing cells-Another miracle cure for spinal cord injury? Nat Rev Neurosci 2: 369-375.
65. Raisman G, Li Y. 2007. Repair of neural pathways by olfactory ensheathing cells. Nat Rev Neurosci 8: 312-319.
66. Ramón-Cueto A, Cordero MI, Santos-Benito FF, Avila J. 2000. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25: 425-435.
67. Ramón-Cueto A, Santos-Benito FF. 2001. Cell therapy to repair injured spinal cords: Olfactory ensheathing glia transplantation. Restor Neurol Neurosci 19: 149-156.
68. Ramón-Cueto A, Valverde F. 1995. Olfactory bulb ensheathing glia: A unique cell type with axonal growth-promoting properties. Glia 14: 163-173.
69. Richter MW, Roskams AJ. 2008. Olfactory ensheathing cell transplantation following spinal cord injury: Hype or hope? Exp Neurol 209: 353-367.
70. Roisen FJ, Klueber KM, Lu CL, Hatcher LM, Dozier A, Shields CB, Maguire S. 2001. Adult human olfactory stem cells. Brain Res 890; 11-22.
71. Schwob JE. 2002. Neural regeneration and the peripheral olfactory system. Anat Rec 269: 33-49.
72. Silver J, Miller JH. 2004. Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146-156.
73. Sørensen A, Moffat K, Thomson C, Barnett SC. 2008. Astrocytes but not olfactory ensheathing cells or Schwann cells promote myelination of CNS axons in vitro. Glia 56: 750-763.
74. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, Piek JJ, El Oakley RM, Choo A, Lee CN, Pasterkamp G, de Kleijn DP. 2007. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1: 129-137.
75. Toft A, Scott DT, Barnett SC, Riddell JS. 2007. Electrophysiological evidence that olfactory cell transplants improve function after spinal cord injury. Brain 130: 970-984.
76. Tomé M, Lindsay SL, Riddell JS, Barnett SC. 2009. Identification of nonepithelial multipotent cells in the embryonic olfactory mucosa. Stem Cells 27: 2196-2208.
77. Uccelli A. 2008. Adult stem cells for spinal cord injury: What types and how do they work? Cytotherapy 10: 541-542.
78. Wright KT, El Masri WE, Osman A, Roberts S, Trivedi J, Ashton BA, Johnson WE. 2008. The cell culture expansion of bone marrow stromal cells from humans with spinal cord injury: Implications for future cell transplantation therapy. Spinal Cord 46: 811-817.
79. Wright KT, El Masri W, Osman A, Chowdhury J, Johnson WE. 2011. Concise review: Bone marrow for the treatment of spinal cord injury: Mechanisms and clinical applications. Stem Cells 29: 169-178.
80. Williams SK, Franklin RJ, Barnett SC. 2004. Response of olfactory ensheathing cells to the degeneration and regeneration of the peripheral olfactory system and the involvement of the neuregulins. J Comp Neurol 470: 50-62.
81. Yamada M, Ivanova A, Yamaguchi Y, Lees MB, Ikenaka K. 1999. Proteolipid protein gene product can be secreted and exhibit biological activity during early development. J. Neurosci 19: 2143-2151.
82. Yan H, Nie X, Kocsis JD. 2001. Hepatocyte growth factor is a mitogen for olfactory ensheathing cells. J Neurosci Res 66: 698-704.